Impact of COVID-19 Pandemic on Antimicrobial Resistance Pattern;Transition from Resistivity to Susceptibility
Global Journal of Medical Pharmaceutical and Biomedical Update
; 17(6):1-5, 2022.
Article
in English
| EMBASE | ID: covidwho-1969977
ABSTRACT
Objective:
The study aimed to assess the antibiotic resistance pattern before and after the pandemic to provide the physicians with general guidance for antibiotic prescribing. Material andMethods:
The yearly antibiograms of different tertiary care hospitals were extracted from Pakistan Antimicrobial Resistance (AMR) Network. The data timeline observed was from January 2016 to December 2020. The data were scrutinized to the most common organism studied with the most recurring antimicrobial used.Results:
Among the Gram-positive organisms, increased resistivity against penicillin was observed against both the organism, while a good susceptibility was observed against vancomycin. Among the Gram-negative organisms, the highest resistance was observed in Ceftriaxone, Ciprofloxacin, and Cotrimoxazole. Staphylococcus aureus and Escherichia coli are the most prevalent organisms in tertiary care hospitals.Conclusion:
While satisfactory susceptibility was observed in Amikacin and Piperacillin/Tazobactam. The post-pandemic era resulted in a decrease in AMR due to significant changes in antibiotic prescribing patterns. This report may guide future antibiotic prescribing.
anti-infective therapy; antibiotic resistance; antibiotic sensitivity; article; coronavirus disease 2019; Escherichia coli; Gram negative bacterium; Gram positive bacterium; human; nonhuman; Pakistan; pandemic; prescribing practice; prescription; Staphylococcus aureus; tertiary care center; amikacin; antibiotic agent; antiinfective agent; ceftriaxone; ciprofloxacin; cotrimoxazole; penicillin derivative; piperacillin plus tazobactam; vancomycin
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Experimental Studies
Language:
English
Journal:
Global Journal of Medical Pharmaceutical and Biomedical Update
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS